TOKAI
VC Fund
Gifu, Japan
TOKAI is a VC fund in Gifu focused on Eyewear and Medical. TOKAI specializes in rental of dispensing pharmacies for hospital linen supplies and outsourcing of outsourced nursing care.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries TOKAI invests in
Stages TOKAI invests in
Countries TOKAI invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Eyewear 1 (25%)
- Medical 1 (25%)
- Robotics 1 (25%)
- Health Care 1 (25%)
- Manufacturing 1 (25%)
Stage
- Angel 1 (25%)
- Series B 1 (25%)
- Series C 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Japan 2 (50%)
- Belgium 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Masahira Kawakami
Executive Officer
|
Executive Officer | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations.Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens.They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel.And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button.In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see. | $11M / Angel / Jul 18, 2022 | ||
| Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations.Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens.They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel.And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button.In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see. | Venture - Series Unknown / Jul 14, 2022 | ||
| INNOPHYS is developing, designing, manufacturing, consulting and distributing robotics equipment for various industries. Their flagship product, Muscle Suit® is a wearable robot supported by artificial muscle technology, well known for its high quality and reasonable price compared with the same kind of support exoskeletons. The company is planningto expand its business to Asia Pacific, Europe, and North America. | $32.3M / Series C / Dec 25, 2019 | ||
| CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments. | $10.7M / Series B |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TOKAI invest in?
TOKAI invests primarily in Eyewear, Medical and Robotics startups, most often at Angel and Series B stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact TOKAI?
Public channels for TOKAI include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TOKAI?
The team at TOKAI includes Masahira Kawakami (Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
